BusinessInspireMD Reports 132% Increase in CGuard™ EPS Sales for the First Quarter of 2018By Nasdaq OMXMay 7, 2018, 8:05 PM UTC
BusinessInspireMD Announces Regulatory Approval and Reimbursement to Commercialize both CGuard EPS™ and MGuard™ Prime Products in VietnamBy Nasdaq OMXApr 30, 2018, 11:34 AM UTC
BusinessInspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 MillionBy Nasdaq OMXApr 3, 2018, 2:28 PM UTC
BusinessInspireMD Announces First Patient Treated with CGuard™ EPS in IndiaBy Nasdaq OMXMar 5, 2018, 1:07 PM UTC
BusinessInspireMD, Inc. Announces Pricing of Public Offering of Common StockBy Nasdaq OMXFeb 27, 2018, 12:01 PM UTC
BusinessInspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South KoreaBy Nasdaq OMXFeb 22, 2018, 3:16 PM UTC
BusinessInspireMD Announces Commercial Launch and First Sales of CGuard™ EPS in IndiaBy Nasdaq OMXFeb 20, 2018, 2:02 PM UTC
BusinessInspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard™ EPS Fourth Quarter Sales Increase 211% Versus Same Period Last yearBy Nasdaq OMXFeb 14, 2018, 12:30 PM UTC
